Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Santen Pharmaceutical Co., Ltd. SNPHF

Full chart Compare
Set alert

Price alert · SNPHF

All alert types
11.43 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

10.99 Day range 10.99
9.51 52-week range 13.06
YTD
+20.19%
1 year
+13.06%

Financial health

Altman Z-Score

5.14 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 15.2×
FY 2017: 25.0×FY 2018: 19.5×FY 2019: 21.3×FY 2020: 30.9×FY 2021: 90.6×FY 2022: 20.5×FY 2023: -29.8×FY 2024: 19.7×FY 2025: 15.2×FY 2026: 15.2×
FY 2017 5y median 15.2× FY 2026
P/S 1.9×
FY 2017: 2.7×FY 2018: 3.1×FY 2019: 2.9×FY 2020: 3.0×FY 2021: 2.5×FY 2022: 2.1×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 1.8×FY 2026: 1.9×
FY 2017 5y median 1.8× FY 2026
P/B 1.9×
FY 2017: 2.1×FY 2018: 2.4×FY 2019: 2.3×FY 2020: 2.4×FY 2021: 2.0×FY 2022: 1.7×FY 2023: 1.5×FY 2024: 1.7×FY 2025: 1.9×FY 2026: 1.9×
FY 2017 5y median 1.7× FY 2026
P/FCF 15.5×
FY 2017: 405×FY 2018: 20.9×FY 2019: 27.7×FY 2020: 23.7×FY 2021: 41.3×FY 2022: 54.7×FY 2023: 35.5×FY 2024: 8.5×FY 2025: 10.1×FY 2026: 15.5×
FY 2017 5y median 15.5× FY 2026
EV/EBITDA 8.2×
FY 2017: 11.9×FY 2018: 12.6×FY 2019: 10.8×FY 2020: 12.7×FY 2021: 8.1×FY 2022: 9.6×FY 2023: 32.8×FY 2024: 9.2×FY 2025: 7.3×FY 2026: 8.2×
FY 2017 5y median 9.2× FY 2026
EV/Sales 1.8×
FY 2017: 2.5×FY 2018: 2.8×FY 2019: 2.6×FY 2020: 2.7×FY 2021: 2.3×FY 2022: 1.9×FY 2023: 1.5×FY 2024: 1.5×FY 2025: 1.6×FY 2026: 1.8×
FY 2017 5y median 1.6× FY 2026
FCF Yield 6.5%
FY 2017: 0.2%FY 2018: 4.8%FY 2019: 3.6%FY 2020: 4.2%FY 2021: 2.4%FY 2022: 1.8%FY 2023: 2.8%FY 2024: 11.8%FY 2025: 9.9%FY 2026: 6.5%
FY 2017 5y median 6.5% FY 2026

Profitability

Gross Margin 55.2%
FY 2017: 62.3%FY 2018: 61.6%FY 2019: 61.2%FY 2020: 60.7%FY 2021: 60.6%FY 2022: 58.8%FY 2023: 59.5%FY 2024: 59.2%FY 2025: 57.0%FY 2026: 55.2%
FY 2017 5y median 58.8% FY 2026
Operating Margin 15.5%
FY 2017: 16.3%FY 2018: 17.2%FY 2019: 19.3%FY 2020: 13.9%FY 2021: 15.1%FY 2022: 13.5%FY 2023: -1.1%FY 2024: 12.8%FY 2025: 15.6%FY 2026: 15.5%
FY 2017 5y median 13.5% FY 2026
Net Margin 12.8%
FY 2017: 10.9%FY 2018: 15.7%FY 2019: 13.7%FY 2020: 9.8%FY 2021: 2.7%FY 2022: 10.2%FY 2023: -5.4%FY 2024: 8.8%FY 2025: 12.1%FY 2026: 12.8%
FY 2017 5y median 10.2% FY 2026
ROE 12.6%
FY 2017: 8.6%FY 2018: 12.3%FY 2019: 11.0%FY 2020: 7.8%FY 2021: 2.2%FY 2022: 8.1%FY 2023: -5.1%FY 2024: 8.7%FY 2025: 12.7%FY 2026: 12.6%
FY 2017 5y median 8.7% FY 2026
ROIC 10.6%
FY 2017: 8.7%FY 2018: 10.7%FY 2019: 10.1%FY 2020: 6.7%FY 2021: 6.2%FY 2022: 7.2%FY 2023: -0.9%FY 2024: 10.0%FY 2025: 10.9%FY 2026: 10.6%
FY 2017 5y median 10.0% FY 2026
ROA 8.8%
FY 2017: 6.7%FY 2018: 9.1%FY 2019: 8.2%FY 2020: 5.8%FY 2021: 1.7%FY 2022: 5.9%FY 2023: -3.5%FY 2024: 6.1%FY 2025: 8.9%FY 2026: 8.8%
FY 2017 5y median 6.1% FY 2026

Growth (YoY)

Revenue -2.2%
FY 2017: 1.9%FY 2018: 13.0%FY 2019: 4.0%FY 2020: 3.2%FY 2021: 3.3%FY 2022: 6.7%FY 2023: 4.8%FY 2024: 8.2%FY 2025: -0.6%FY 2026: -2.2%
FY 2017 FY 2026
Operating Income -2.9%
FY 2017: -59.5%FY 2018: 19.1%FY 2019: 16.6%FY 2020: -25.6%FY 2021: 12.7%FY 2022: -5.1%FY 2023: -108.6%FY 2024: 1347.3%FY 2025: 21.6%FY 2026: -2.9%
FY 2017 FY 2026
EPS (diluted) 11.0%
FY 2017: -58.9%FY 2018: 63.9%FY 2019: -9.3%FY 2020: -24.8%FY 2021: -71.1%FY 2022: 298.4%FY 2023: -156.8%FY 2024: 287.6%FY 2025: 43.3%FY 2026: 11.0%
FY 2017 FY 2026
Free Cash Flow -32.0%
FY 2017: -90.0%FY 2018: 2350.2%FY 2019: -25.4%FY 2020: 25.1%FY 2021: -51.2%FY 2022: -32.0%FY 2023: 23.1%FY 2024: 393.4%FY 2025: -12.4%FY 2026: -32.0%
FY 2017 FY 2026

Financial Health

Current Ratio 2.6×
FY 2017: 2.9×FY 2018: 2.9×FY 2019: 3.2×FY 2020: 3.2×FY 2021: 2.6×FY 2022: 2.4×FY 2023: 2.4×FY 2024: 2.5×FY 2025: 2.6×FY 2026: 2.6×
FY 2017 5y median 2.5× FY 2026
Quick Ratio 1.9×
FY 2017: 2.4×FY 2018: 2.5×FY 2019: 2.6×FY 2020: 2.7×FY 2021: 2.1×FY 2022: 2.0×FY 2023: 1.9×FY 2024: 2.1×FY 2025: 2.0×FY 2026: 1.9×
FY 2017 5y median 2.0× FY 2026
Debt / Equity 0.1×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -0.7×
FY 2017: -0.8×FY 2018: -1.2×FY 2019: -1.2×FY 2020: -1.5×FY 2021: -0.8×FY 2022: -0.9×FY 2023: -1.7×FY 2024: -1.2×FY 2025: -0.9×FY 2026: -0.7×
FY 2017 5y median -0.9× FY 2026
Interest Coverage 22.7×
FY 2017: 20.8×FY 2018: 89.1×FY 2019: 15.7×FY 2020: 14.0×FY 2021: 25.4×FY 2022: 29.7×FY 2023: -2.1×FY 2024: 14.5×FY 2025: 17.3×FY 2026: 22.7×
FY 2017 5y median 17.3× FY 2026

Dividends

Dividend Yield 2.2%
FY 2017: 2.0%FY 2018: 1.5%FY 2019: 1.6%FY 2020: 1.4%FY 2021: 1.8%FY 2022: 2.1%FY 2023: 2.8%FY 2024: 2.3%FY 2025: 2.2%FY 2026: 2.2%
FY 2017 5y median 2.2% FY 2026
Payout Ratio 33.8%
FY 2017: 49.5%FY 2018: 29.9%FY 2019: 33.1%FY 2020: 43.9%FY 2021: 163.8%FY 2022: 44.1%FY 2023: -84.3%FY 2024: 44.6%FY 2025: 33.4%FY 2026: 33.8%
FY 2017 5y median 33.8% FY 2026

Annual · latest fiscal year ends 2026-03-31